Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 7461–7480 of 17,529 recalls

April 12, 2019· CMC Enterprise Pharmacy

Recalled Item: Vancomycin 1500 mg in NS 250 mL bag

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 12, 2019· CMC Enterprise Pharmacy

Recalled Item: Sodium Citrate 4%

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 12, 2019· CMC Enterprise Pharmacy

Recalled Item: Magnesium Sulfate 1 GM in NS 50 mL bag

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 12, 2019· CMC Enterprise Pharmacy

Recalled Item: Vancomycin 1750 mg in 0.9% Sodium Chloride 500 mL bag

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 12, 2019· CMC Enterprise Pharmacy

Recalled Item: Vancomycin 1000 mg in NS 250 mL bag

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 12, 2019· Teva Pharmaceuticals USA

Recalled Item: Amoxicillin for Oral Suspension USP

The Issue: Subpotent Product: assay results for Amoxicillin were below

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 11, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Divalproex Sodium Extended-Release Tablets

The Issue: cGMP deviations: Product was exposed above 50% relative

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 10, 2019· LUPIN SOMERSET

Recalled Item: Morphine Sulfate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 10, 2019· LUPIN SOMERSET

Recalled Item: Morphine Sulfate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 10, 2019· LUPIN SOMERSET

Recalled Item: Morphine Sulfate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 10, 2019· LUPIN SOMERSET

Recalled Item: Morphine Sulfate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 10, 2019· LUPIN SOMERSET

Recalled Item: Morphine Sulfate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 9, 2019· SELECT DISTRIBUTIONS LLC

Recalled Item: Aphrodisiac Platinum 40000

The Issue: Marketed without an approved NDA/ANDA: FDA analysis has

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
April 8, 2019· Customceutical Compounding

Recalled Item: BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML...

The Issue: Lack of assurance of sterility for injectables and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 8, 2019· American Health Packaging

Recalled Item: GlipiZIDE Extended-release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 8, 2019· Customceutical Compounding

Recalled Item: HCG (CHORIONIC GONADOTROPIN 1000 IU/ML PEP 25 mg/mL) inj 5

The Issue: Lack of assurance of sterility for injectables and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 8, 2019· Customceutical Compounding

Recalled Item: Trimix HIGH (Papaverine HCl 30 mg/mL Phentolamine Mesylate 2 mg/mL

The Issue: Lack of assurance of sterility for injectables and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 8, 2019· Customceutical Compounding

Recalled Item: BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML...

The Issue: Lack of assurance of sterility for injectables and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 8, 2019· Customceutical Compounding

Recalled Item: Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5

The Issue: Lack of assurance of sterility for injectables and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 8, 2019· Customceutical Compounding

Recalled Item: Lipoplex (METHIONINE 25 MG/ML INOSITOL 50 MG/ML CHOLINE CHLORIDE 50

The Issue: Lack of assurance of sterility for injectables and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund